ClinicalTrials.Veeva

Menu

Influence of Endurance Exercise and Histamine Receptors on the Gene Expression in Skeletal Muscle

U

University Ghent

Status

Completed

Conditions

Histamine
Exercise

Treatments

Drug: Placebo: Placebo + exercise training.
Drug: H1 blockade: H1 receptor antagonist + exercise training
Drug: H2 Blockade: H2 receptor antagonist + exercise training

Study type

Interventional

Funder types

Other

Identifiers

NCT05131555
AET - BC-10237

Details and patient eligibility

About

Blocking histamine H1/H2 receptors blunts chronic endurance training adaptations. The current study addresses a twofold research question: "What is the influence of endurance training (1) and histamine H1 and H2 signaling (2) on the gene expression in human skeletal muscle." Results from this study will yield more insights into the molecular mechanisms of adaptations to exercise training.

Enrollment

14 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male and female
  • 18-45 years
  • not to medium physically active

Exclusion criteria

  • Smoking
  • Chronic disease
  • Supplement or medication intake
  • Seasonal allergies

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

14 participants in 3 patient groups, including a placebo group

1: Placebo
Placebo Comparator group
Description:
lactose
Treatment:
Drug: Placebo: Placebo + exercise training.
H1 blockade
Experimental group
Description:
540 mg Fexofenadine
Treatment:
Drug: H1 blockade: H1 receptor antagonist + exercise training
H2 blockade
Experimental group
Description:
40 mg Famotidine
Treatment:
Drug: H2 Blockade: H2 receptor antagonist + exercise training

Trial contacts and locations

1

Loading...

Central trial contact

Wim Derave, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems